BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4212164)

  • 1. Methodology for the evaluation of pentazocine, prototype of the new morphine agonist-antagonist analgesics.
    Seevers MH
    Int J Clin Pharmacol; 1974 Apr; 7(3):167-73. PubMed ID: 4212164
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation in nonhuman primates: evaluation of the physical dependence capacities of oripavine-thebaine partial agonists in patas monkeys.
    Cowan A
    Adv Biochem Psychopharmacol; 1973; 8(0):427-38. PubMed ID: 4211992
    [No Abstract]   [Full Text] [Related]  

  • 3. Arylpyrrolidines as narcotic antagonists.
    McCarthy DA
    Adv Biochem Psychopharmacol; 1973; 8(0):145-55. PubMed ID: 4211813
    [No Abstract]   [Full Text] [Related]  

  • 4. Behavioral and morphine-antagonist effects of the optical isomers of pentazocine and cyclazocine.
    McMillan DE; Harris LS
    J Pharmacol Exp Ther; 1972 Mar; 180(3):269-79. PubMed ID: 5012778
    [No Abstract]   [Full Text] [Related]  

  • 5. Antagonists in the 5-phenyl-benzomorphan series.
    Clarke FH; Hill RT; Saelens JK; Yokoyama N
    Adv Biochem Psychopharmacol; 1973; 8(0):81-9. PubMed ID: 4211809
    [No Abstract]   [Full Text] [Related]  

  • 6. Narcotic-antagonist assay procedures in dogs.
    Dewey WL
    Adv Biochem Psychopharmacol; 1973; 8(0):263-72. PubMed ID: 4794991
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential usefulness of single-dose acute physical dependence on and tolerance to morphine for the evaluation of narcotic antagonists.
    Jacob JJ; Barthelemy CD; Tremblay EC; Colombel MC
    Adv Biochem Psychopharmacol; 1973; 8(0):299-318. PubMed ID: 4800176
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of narcotics and narcotic antagonists on operant behavior.
    McMillan DE
    Adv Biochem Psychopharmacol; 1973; 8(0):345-59. PubMed ID: 4604406
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl-2'-hydroxy-5,9-dimethyl-6,7-benzomorphan (cyclazocine, WIN-20,740, ARC II-c-3).
    Martin WR; Fraser HF; Gorodetzky CW; Rosenberg DE
    J Pharmacol Exp Ther; 1965 Dec; 150(3):426-36. PubMed ID: 5322320
    [No Abstract]   [Full Text] [Related]  

  • 10. Bridged amino tetralins.
    Freed ME; Potoski JR; Freed EH; Gluckman MI; Malis JL
    Adv Biochem Psychopharmacol; 1973; 8(0):137-44. PubMed ID: 4211844
    [No Abstract]   [Full Text] [Related]  

  • 11. Narcotic antagonist activity of substituted 1,2,4,5-tetrahydro-3H,3-benzazepines.
    Giering JE; Davidson TA; Shetty BV; Truant AP
    Adv Biochem Psychopharmacol; 1973; 8(0):167-86. PubMed ID: 4800174
    [No Abstract]   [Full Text] [Related]  

  • 12. Demonstration of tolerance to and physical dependence of N-allylnormorphine (nalorphine).
    Martin WR; Gorodetzky CW
    J Pharmacol Exp Ther; 1965 Dec; 150(3):437-42. PubMed ID: 5322321
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of tricyclic antidepressants on analgesic activity in laboratory animals.
    Lee RL; Spencer PS
    Postgrad Med J; 1980; 56 Suppl 1():19-24. PubMed ID: 7190280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self administration: positive and negative reinforcing properties of morphine antagonists in rhesus monkeys.
    Hoffmeister F; Wuttke W
    Adv Biochem Psychopharmacol; 1973; 8(0):361-9. PubMed ID: 4212335
    [No Abstract]   [Full Text] [Related]  

  • 15. Agonist and antagonist interactions of opioids on acetic acid-induced abdominal stretching in mice.
    Taber RI; Greenhouse DD; Rendell JK; Irwin S
    J Pharmacol Exp Ther; 1969 Sep; 169(1):29-38. PubMed ID: 5804610
    [No Abstract]   [Full Text] [Related]  

  • 16. Certain theoretical and practical considerations involved in evaluating the overall abuse potential of opiate agonists and antagonists.
    Fraser HF
    Adv Biochem Psychopharmacol; 1973; 8(0):439-53. PubMed ID: 4604198
    [No Abstract]   [Full Text] [Related]  

  • 17. Interactions of narcotic antagonists.
    Harris LS
    Ann N Y Acad Sci; 1976; 281():288-96. PubMed ID: 828466
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interaction of naloxone, nalorphine and pentazocine with narcotic analgesics at the metabolic level].
    Ardentova NN; Bender KI; Panchenko EV; Khokhlova DS
    Farmakol Toksikol; 1981; 44(5):554-8. PubMed ID: 7308434
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
    Lamas X; Farre M; Cami J
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1485-92. PubMed ID: 8138958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereospecificity of mixed-action opioid agonist/antagonists in morphine-tolerant squirrel monkeys.
    Dykstra LA; Picker MJ; Powell K
    NIDA Res Monogr; 1990; 105():375. PubMed ID: 1876046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.